ArticleDrug design, development and therapy2025

Research Trends of Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer: A Bibliometric Analysis.

Xiaoyan Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.